Abstract |
The antagonistic effect of YM461 [1-(3-phenylpropyl)-4-[2- (3-pyridyl)thiazolidin-4-ylcarbonyl] piperazine fumarate] against platelet-activating factor (PAF) was examined in several in vitro and in vivo systems. We found that YM461 inhibited [3H]PAF binding to rabbit platelet membranes with a pKi value of 8.90. YM461 inhibited PAF induced rabbit and human platelet aggregation with pA2 values of 7.52 and 7.29, respectively; the slopes of the Schild plots were 1.07 and 1.01, respectively. However, YM461 at 10(-4)M did not affect rabbit and human platelet aggregation induced by ADP, collagen, arachidonic acid or epinephrine. YM461 inhibited PAF induced death in mice with an ED50 (50% effective dose) value of 0.35 mg/kg p.o. YM461 at doses above 0.3 mg/kg i.v. inhibited PAF induced hypotension in rats. YM461 showed a dose-dependent inhibition of PAF induced hemoconcentration in rats with ED50 values of 0.15 and 0.21 mg/kg p.o., respectively, at 0.5 and 1 hr after oral administration. The anti-PAF effect of YM461 persisted more than 6 hr after 3 mg/kg p.o. in rats. YM461 inhibited the bronchoconstriction induced by PAF with an ED50 value of 1.2 mg/kg p.o. in anesthetized guinea pigs. Furthermore, the compound at doses above 3 mg/kg p.o. significantly inhibited antigen-induced anaphylactic asthma in conscious guinea pigs pretreated with mepyramine and propranolol. These results indicate that YM461 is a selective, potent and orally active PAF antagonist.
|
Authors | T Yamada, M Saito, T Mase, H Hara, H Nagaoka, K Murase, K Tomioka |
Journal | Lipids
(Lipids)
Vol. 26
Issue 12
Pg. 1179-83
(Dec 1991)
ISSN: 0024-4201 [Print] United States |
PMID | 1668114
(Publication Type: Journal Article)
|
Chemical References |
- Azepines
- Platelet Activating Factor
- Platelet Aggregation Inhibitors
- Platelet Membrane Glycoproteins
- Pyridines
- Receptors, Cell Surface
- Receptors, G-Protein-Coupled
- Thiazoles
- Thiazolidines
- Triazoles
- platelet activating factor receptor
- WEB 2086
- YM 461
|
Topics |
- Administration, Oral
- Animals
- Azepines
(pharmacology, toxicity)
- Blood Platelets
(metabolism)
- Blood Pressure
(drug effects)
- Cell Membrane
(metabolism)
- Dose-Response Relationship, Drug
- Guinea Pigs
- Humans
- Male
- Mice
- Mice, Inbred ICR
- Platelet Activating Factor
(antagonists & inhibitors, metabolism, toxicity)
- Platelet Aggregation
(drug effects)
- Platelet Aggregation Inhibitors
(administration & dosage, pharmacology)
- Platelet Membrane Glycoproteins
- Pyridines
(administration & dosage, pharmacology)
- Rabbits
- Rats
- Rats, Inbred Strains
- Receptors, Cell Surface
(antagonists & inhibitors, metabolism)
- Receptors, G-Protein-Coupled
- Thiazoles
(administration & dosage, pharmacology)
- Thiazolidines
- Triazoles
(pharmacology, toxicity)
|